Table 3.
Association of type of KRT (KT versus HD) with incidence of 28-day COVID-19-related mortality, overall and by reason for COVID-19 screening, presented as HRs with 95% CIs
| Total, events (n) |
Symptoms, events (n) |
Contact/routine, events (n) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Model | HD 281 (1174) | KT 84 (496) | P-value | HD 205 (721) | KT 75 (424) | P-value | HD 76 (453) | KT 9 (72) | P-value |
| Model 1 | Ref. | 0.67 (0.52–0.85) | 0.001 | Ref. | 0.57 (0.44–0.75) | <0.001 | Ref. | 0.71 (0.36–1.43) | 0.34 |
| Model 2 | Ref. | 1.14 (0.88–1.47) | 0.33 | Ref. | 1.07 (0.80–1.43) | 0.65 | Ref. | 0.99 (0.49–1.99) | 0.97 |
| Model 3 | Ref. | 1.30 (1.00–1.68) | 0.05 | Ref. | 1.21 (0.90–1.61) | 0.21 | Ref. | 1.15 (0.57–2.34) | 0.69 |
| Model 4 | Ref. | 1.39 (1.07–1.81) | 0.02 | Ref. | 1.32 (0.98–1.77) | 0.07 | Ref. | 1.19 (0.58–2.46) | 0.63 |
| Model 5 | Ref. | 1.78 (1.22–2.61) | 0.003 | Ref. | 2.00 (1.31–3.06) | 0.001 | Ref. | 0.57 (0.17–1.91) | 0.36 |
Model 1: crude; Model 2: age and sex; Model 3: Model 2 + frailty; Model 4: Model 3 + obesity, hypertension, diabetes, heart failure, chronic lung disease and smoking; Model 5: Model 4 + duration of kidney failure and kidney function.